Skip to main content

Day: May 6, 2025

Alpha Tau to Participate in May Investor Conferences

JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will presentation in the following investor conferences in May 2025.Event: H.C. Wainwright 3rd Annual BioConnect Investor ConferenceFormat: Fireside ChatDate: May 20, 2025Time: 3:30 – 4:00PM ETLocation: New York, NYEvent: Lytham Partners Spring 2025 Investor ConferenceFormat: 1×1 MeetingsDate: May 29, 2025Location: VirtualMr. Levy will be available for 1×1 investor meetings at both conferences. Please reach out to your H.C. Wainwright and Lytham Partners representatives to schedule. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli...

Continue reading

Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan’s Medical Equipment (“Lehan”), a healthcare company offering home medical equipment with specialties in respiratory care and women’s health. “Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women’s health and a deep commitment to community engagement,” said Viemed Chief Executive Officer Casey Hoyt. “Lehan gives us a strong platform to execute our growth strategy in a large and fast-growing market with very familiar...

Continue reading

Netcoins Canada Provides Q1 2025 Results

VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group, and TerraZero is pleased to provide Netcoins’ Canadian operations’ unaudited first-quarter financial guidance for the period ended March 31, 2025. All financial references are in Canadian dollars (CAD) unless otherwise noted. Q1 2025 Financial ResultsQ1 2025 trading volume was approximately $334 million, compared to Q1 2024’s trading volume of $265 million, marking a 26% increase YoY Total Q1 2025 trading and staking revenue is expected to be $3.3 million, marking an increase of 6% over Q1 2024 revenues of $3.1 million. Gross margin from trading remained consistent...

Continue reading

Brixton Metals Provides Exploration Plans for Gold and Copper Drill Targets for its Fully Funded 2025 Program at its Thorn Project

VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce its 2025 exploration plans for its wholly owned Thorn Copper-Gold Project. The 2945 square kilometer project is located in Northwest British Columbia, Canada, approximately 90km northeast from Juneau, AK. Highlights of Exploration Plan for 2025:The 2025 season has a two-pronged approach: i) expand near surface gold mineralization and ii) drill for new, near surface copper porphyry discoveries for a combined 8000m to 10,000m.Shallow drilling to establish the continuity and strike of new feeder-structure high-sulphidation style gold-copper-silver mineralization encountered in holes 307/294/221 within the Camp Creek Corridor. Hole 307 returned 8.00m of 4.52 g/t...

Continue reading

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that it will report its first quarter 2025 financial results and provide a corporate update on the cytisinicline development program on Tuesday May 13, 2025, at 8:30 AM EDT. To access the webcast, please use the following link: 1Q25 Earnings Webcast. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. & Canada) or 201-689-7817 (International) and referencing conference ID 13752599. A webcast replay will be available approximately three hours after the call and archived on the website...

Continue reading

UMeWorld Releases Clinical Results: DAG Oil Shows Significant Reductions in Uric Acid, Cholesterol, Triglycerides, and Weight

MIAMI, May 06, 2025 (GLOBE NEWSWIRE) — UMeWorld Limited (OTC: UMEWF) today announced the results of a clinical study demonstrating the metabolic benefits of diacylglycerol (DAG) oil, the active ingredient in its functional cooking oil brand, DAGola. The study confirmed that regular consumption of DAG oil led to significant improvements in key health markers, including uric acid, triglycerides, cholesterol, and body weight. The study, titled “The study on the effects of diacylglycerol (DAG) oil in patients with elevated blood glucose levels and overweight”, was conducted with 820 adult participants aged 18 to 75 who were overweight (BMI > 24.0 kg/m²) and had either glycated hemoglobin (HbA1c) levels ≥ 5.7% or fasting blood glucose ≥ 5.6 mmol/L. Participants agreed to adopt a structured dietary intervention that included exclusive...

Continue reading

Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ETSOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will report the first quarter 2025 financial results and provide a business update on May 13, 2025, after the close of the market. The announcement will be followed by a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET. Listen-Only WebcastThe listen-only webcast will be made available on the Company’s website at www.allogene.com under the Investors tab in the News and Events section. A replay will be available on the Company’s website for...

Continue reading

Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion

Arabic, Italian, and Spanish-language websites unlock commercial access to regions representing over 1.4 billion people Multilingual rollout aligns with product readiness and accelerates international sales pipeline development NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of three new localized websites in Arabic, Italian, and Spanish. This rollout supports the Company’s global growth plans and international sales expansion by opening digital and commercial access to some of the world’s fastest-growing, high-demand regions for workplace safety and compliance solutions. The newly launched websites form part...

Continue reading

PodcastOne (NASDAQ: PODC) and Kaitlyn Bristowe Celebrate 10 Year Anniversary of Her Season of ABC’s The Bachelorette with Special Edition of Off the Vine with Kaitlyn Bristowe Podcast

Off the Vine All Time Downloads 179 Million with Over 830 Episodes Since Debut LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) — PodcastOne (NASDAQ: PODC), a leading publisher and podcast sales network, announced today that podcast host Kaitlyn Bristowe is celebrating her pinnacle season of ABC’s long running Bachelorette franchise with a special nostalgic edition of her People’s Choice Award nominated podcast, Off the Vine with Kaitlyn Bristowe. Twice weekly episodes launch May 6, 2025 and Bristowe, arguably one of the most popular Bachelorette’s in series history, celebrates the 10 year anniversary of her season of the show. Kicking off the first episode is Bristowe taking a lookback on her entire season and reacting to scenes she hasn’t revisited in ten years. Listeners will be along for the ride as Bristowe reacts to key show moments...

Continue reading

Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases

Two posters presented at Digestive Disease Week (DDW) 2025 Preclinical results indicate that PALI-2108 effectively modulates inflammatory pathways in the colon, promoting a favorable immune response Company advancing Phase 1a/b study of PALI-2108 and has demonstrated a favorable safety profile in single-ascending-dose cohorts Carlsbad, CA, May 06, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced the presentation of positive preclinical data from PALI-2108, an orally administered, colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug in development for patients with ulcerative colitis...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.